US 11001844
CRISPR/Cas-related methods and compositions for treating herpes simplex virus
granted A61PA61P27/02A61P31/22
Quick answer
US patent 11001844 (CRISPR/Cas-related methods and compositions for treating herpes simplex virus) held by Editas Medicine, Inc. expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Editas Medicine, Inc.
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P27/02, A61P31/22